Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ALTEX

Showing results (361-370 of 1,366) with videos related to

Pageof 137
Sort By:
ALTEX|December 2, 2011
A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCAPaul A Locke, D Bruce Myers
ALTEX|December 2, 2011
The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakageMaría Moreno-Villanueva, Tobias Eltze, Dirk Dressler, et al.
ALTEX|November 22, 2011
No clinical relevance of approved animal experiments after seventeen yearsToni Lindl, Manfred Voelkel
ALTEX|July 1, 2009
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammationAnja Henn, Søren Lund, Maj Hedtjärn, et al.
ALTEX|July 1, 2009
Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro - an overviewMahtab Bahramsoltani, Johanna Plendl, Pawel Janczyk, et al.
ALTEX|April 25, 2009
Abstracts of the 15th Congress on Alternatives to Animal Experimentation, Linz, Austria, 2008
ALTEX|October 22, 2021
Animal metrics: Tracking contributions of new approach methods to reduced animal useM Sue Marty, Amanda K Andrus, Katherine A Groff
ALTEX|July 8, 2019
Machine learning prediction of cyanobacterial toxin (microcystin) toxicodynamics in humansStefan Altaner, Sabrina Jaeger, Regina Fotler, et al.
ALTEX|April 12, 2022
Corrigendum to TBBPA Targets Converging Key Events of Human Oligodendrocyte Development Resulting in Two Novel AOPsJördis Klose, Julia Tigges, Stefan Masjosthusmann, et al.
ALTEX|April 11, 2022
The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possibleManuela Cassotta, Hugo Geerts, Lise Harbom, et al.
Pageof 137

Showing results (361-370 of 1,366) with videos related to

Sort By:
Pageof 137
ALTEX|December 2, 2011
A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCAPaul A Locke, D Bruce Myers
ALTEX|December 2, 2011
The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakageMaría Moreno-Villanueva, Tobias Eltze, Dirk Dressler, et al.
ALTEX|November 22, 2011
No clinical relevance of approved animal experiments after seventeen yearsToni Lindl, Manfred Voelkel
ALTEX|July 1, 2009
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammationAnja Henn, Søren Lund, Maj Hedtjärn, et al.
ALTEX|July 1, 2009
Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro - an overviewMahtab Bahramsoltani, Johanna Plendl, Pawel Janczyk, et al.
ALTEX|April 25, 2009
Abstracts of the 15th Congress on Alternatives to Animal Experimentation, Linz, Austria, 2008
ALTEX|October 22, 2021
Animal metrics: Tracking contributions of new approach methods to reduced animal useM Sue Marty, Amanda K Andrus, Katherine A Groff
ALTEX|July 8, 2019
Machine learning prediction of cyanobacterial toxin (microcystin) toxicodynamics in humansStefan Altaner, Sabrina Jaeger, Regina Fotler, et al.
ALTEX|April 12, 2022
Corrigendum to TBBPA Targets Converging Key Events of Human Oligodendrocyte Development Resulting in Two Novel AOPsJördis Klose, Julia Tigges, Stefan Masjosthusmann, et al.
ALTEX|April 11, 2022
The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possibleManuela Cassotta, Hugo Geerts, Lise Harbom, et al.
Pageof 137